• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

混合性神经节细胞瘤-垂体腺瘤:对一种罕见鞍区肿瘤发病机制的见解

Mixed Gangliocytoma-Pituitary Adenoma: Insights on the Pathogenesis of a Rare Sellar Tumor.

作者信息

Lopes M Beatriz S, Sloan Emily, Polder Julie

机构信息

Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA.

出版信息

Am J Surg Pathol. 2017 May;41(5):586-595. doi: 10.1097/PAS.0000000000000806.

DOI:10.1097/PAS.0000000000000806
PMID:28079576
Abstract

Gangliocytomas originating in the sellar region are rare; most are tumors composed of gangliocytic and pituitary adenomatous elements, forming the so-called mixed gangliocytoma-pituitary adenoma. The majority of mixed gangliocytoma adenomas are associated with endocrinopathies, mainly acromegaly and less often Cushing disease and hyperprolactinemia. In the present study, 10 cases of mixed gangliocytoma and somatotroph adenomas were evaluated for patterns of cellular differentiation and expression of lineage-specific transcription factors. The tumors were characterized by immunohistochemistry for pituitary hormones, cytokeratins, Pit-1, and the neuronal markers NeuN, neurofilaments (NFP), and MAP2. Double-labeling immunohistochemistry for Pit-1/GH, Pit-1/NFP, Pit-1/MAP2, and NeuN/GH was performed in 9/10 tumors. Our data demonstrate that both adenomatous and ganglionic cells express the acidophilic lineage transcription factor Pit-1. Although mixed gangliocytomas and somatotroph adenomas show histologically distinct cellular populations, there is at least a small population of cells that coexpress the Pit-1 transcription factor and neuronal-associated cytoskeletal proteins favoring the theory of transdifferentiation of neuroendocrine cells into neuronal elements of these mixed tumors.

摘要

起源于鞍区的神经节细胞瘤很罕见;大多数是由神经节细胞和垂体腺瘤成分组成的肿瘤,形成所谓的混合性神经节细胞瘤 - 垂体腺瘤。大多数混合性神经节细胞瘤腺瘤与内分泌病相关,主要是肢端肥大症,较少见的是库欣病和高催乳素血症。在本研究中,对10例混合性神经节细胞瘤和生长激素细胞腺瘤进行了细胞分化模式和谱系特异性转录因子表达的评估。通过对垂体激素、细胞角蛋白、Pit-1以及神经元标志物NeuN、神经丝(NFP)和微管相关蛋白2(MAP2)进行免疫组织化学对肿瘤进行特征性分析。在10个肿瘤中的9个进行了Pit-1/生长激素(GH)、Pit-1/NFP、Pit-1/MAP2和NeuN/GH的双重免疫组织化学标记。我们的数据表明,腺瘤细胞和神经节细胞均表达嗜酸性谱系转录因子Pit-1。尽管混合性神经节细胞瘤和生长激素细胞腺瘤在组织学上显示出不同的细胞群,但至少有一小部分细胞共表达Pit-1转录因子和神经元相关的细胞骨架蛋白,这支持了神经内分泌细胞转分化为这些混合肿瘤神经元成分的理论。

相似文献

1
Mixed Gangliocytoma-Pituitary Adenoma: Insights on the Pathogenesis of a Rare Sellar Tumor.混合性神经节细胞瘤-垂体腺瘤:对一种罕见鞍区肿瘤发病机制的见解
Am J Surg Pathol. 2017 May;41(5):586-595. doi: 10.1097/PAS.0000000000000806.
2
Observation of Clinicopathologic Features of Pituitary Adenoma With Neuronal Differentiation.观察具有神经元分化特征的垂体腺瘤的临床病理特征。
Front Endocrinol (Lausanne). 2022 Mar 15;13:848762. doi: 10.3389/fendo.2022.848762. eCollection 2022.
3
Pituitary adenoma-neuronal choristoma is a pituitary adenoma with ganglionic differentiation.垂体腺瘤-神经组织错构瘤是一种具有神经节分化的垂体腺瘤。
Exp Mol Pathol. 2015 Dec;99(3):628-31. doi: 10.1016/j.yexmp.2015.11.004. Epub 2015 Nov 10.
4
Mixed gangliocytoma-pituitary adenoma in the sellar region: a large-scale single-center experience.鞍区混合性神经节细胞瘤-垂体腺瘤:一项大规模单中心经验。
Acta Neurochir (Wien). 2018 Oct;160(10):1989-1999. doi: 10.1007/s00701-018-3632-7. Epub 2018 Aug 14.
5
Ganglion cell containing pituitary adenomas: signs of neuronal differentiation in adenoma cells.含神经节细胞的垂体腺瘤:腺瘤细胞中神经元分化的迹象。
Acta Neuropathol. 2006 Jul;112(1):21-8. doi: 10.1007/s00401-006-0055-y. Epub 2006 May 13.
6
Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.静默型 3 型垂体腺瘤并非总是静默的,它们代表分化不良的单型多激素分泌垂体瘤-1 谱系腺瘤。
Mod Pathol. 2016 Feb;29(2):131-42. doi: 10.1038/modpathol.2015.151. Epub 2016 Jan 8.
7
Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.Pit-1免疫染色在鉴别原始分化型垂体腺瘤与无功能细胞腺瘤中的应用
Endocr Pathol. 2017 Dec;28(4):287-292. doi: 10.1007/s12022-017-9503-6.
8
Transsphenoidal Surgery for Mixed Pituitary Gangliocytoma-Adenomas.经蝶窦手术治疗混合性垂体神经节细胞瘤-腺瘤
World Neurosurg. 2017 Dec;108:310-316. doi: 10.1016/j.wneu.2017.08.174. Epub 2017 Sep 5.
9
Pituitary Gangliocytoma Producing TSH and TRH: A Review of "Gangliocytomas of the Sellar Region".垂体促甲状腺激素瘤和促甲状腺激素释放激素瘤:“鞍区神经节细胞瘤”述评。
J Clin Endocrinol Metab. 2020 Oct 1;105(10):3109-21. doi: 10.1210/clinem/dgaa474.
10
Transdifferentiation of Neuroendocrine Cells: Gangliocytoma Associated With Two Pituitary Adenomas of Different Lineage in MEN1.神经内分泌细胞的转分化:与多发性内分泌腺瘤1型中不同谱系的两个垂体腺瘤相关的神经节细胞瘤。
Am J Surg Pathol. 2017 Jun;41(6):849-853. doi: 10.1097/PAS.0000000000000803.

引用本文的文献

1
Clinical Characteristics, Diagnosis, and Treatment of Thyroid Stimulating Hormone-Secreting Pituitary Neuroendocrine Tumor (TSH PitNET): A Single-Center Experience.促甲状腺激素(TSH)分泌型垂体神经内分泌肿瘤(TSH PitNET)的临床特征、诊断和治疗:单中心经验。
Endocrinol Metab (Seoul). 2024 Apr;39(2):387-396. doi: 10.3803/EnM.2023.1877. Epub 2024 Feb 5.
2
IgG4-associated hypophysitis coexisting with MALT lymphoma and gangliocytoma: first case report and literature review.IgG4相关性垂体炎合并黏膜相关淋巴组织淋巴瘤和神经节细胞瘤:首例病例报告及文献复习
Front Neurol. 2023 Nov 9;14:1253821. doi: 10.3389/fneur.2023.1253821. eCollection 2023.
3
Endoscopic Endonasal Surgery for Uncommon Pathologies of the Sellar and Parasellar Regions.
经鼻内镜手术治疗鞍区和鞍旁区域罕见病变
Adv Tech Stand Neurosurg. 2023;48:139-205. doi: 10.1007/978-3-031-36785-4_7.
4
Multiple tumorous lesions of the pituitary gland.垂体多瘤性病变。
Hormones (Athens). 2022 Dec;21(4):653-663. doi: 10.1007/s42000-022-00392-9. Epub 2022 Aug 10.
5
Correlation Analysis of Magnetic Resonance Imaging Characteristics and Prognosis of Invasive Pituitary Adenomas in Neurosurgery Hospitals.神经外科医院侵袭性垂体腺瘤的磁共振成像特征与预后的相关性分析。
J Healthc Eng. 2022 Apr 21;2022:8280540. doi: 10.1155/2022/8280540. eCollection 2022.
6
Observation of Clinicopathologic Features of Pituitary Adenoma With Neuronal Differentiation.观察具有神经元分化特征的垂体腺瘤的临床病理特征。
Front Endocrinol (Lausanne). 2022 Mar 15;13:848762. doi: 10.3389/fendo.2022.848762. eCollection 2022.
7
Sellar Gangliocytoma: Case Report and Review of an Extremely Rare Tumour.鞍区神经节细胞瘤:一例极其罕见肿瘤的病例报告及文献复习
Case Rep Neurol. 2021 Jul 19;13(2):475-482. doi: 10.1159/000517368. eCollection 2021 May-Aug.
8
Unilateral hydrocephalus from a gangliocytoma-somatotrophinoma: first reported case.神经节细胞瘤-生长激素细胞瘤所致单侧脑积水:首例报告病例
Endocrinol Diabetes Metab Case Rep. 2021 Jul 1;2021. doi: 10.1530/EDM-21-0037.
9
Gonadotroph tumours with a low SF-1 labelling index are more likely to recur and are associated with enrichment of the PI3K-AKT pathway.SF-1 低标记指数的促性腺细胞瘤更有可能复发,并与 PI3K-AKT 通路的富集有关。
Neuropathol Appl Neurobiol. 2021 Apr;47(3):415-427. doi: 10.1111/nan.12675. Epub 2020 Dec 20.
10
Pituitary Gangliocytoma Producing TSH and TRH: A Review of "Gangliocytomas of the Sellar Region".垂体促甲状腺激素瘤和促甲状腺激素释放激素瘤:“鞍区神经节细胞瘤”述评。
J Clin Endocrinol Metab. 2020 Oct 1;105(10):3109-21. doi: 10.1210/clinem/dgaa474.